A. Tschöp, A. Marx, A. R. Sreekanth, C. Schneider
FULL PAPER
(1R,2R)-2-(Allyloxy)-1,2-diphenylethanol (5):[22] Yield 198 mg,
78%, colorless liquid. [α]2D5 = –27.2 (c = 1.1, CH2Cl2); ee = 95%.
The enantiomeric assay: Chiralcel OD, isocratic (n-hexane/iPrOH,
97:3, flow 1 mL/min) λmax = 203 nm, (1S,2S): 8.9 min, (1R,2R):
CDCl3): δ = 14.0, 19.5, 32.0, 69.0, 78.8, 87.7, 127.4, 127.7, 127.8,
127.9, 128.0, 128.1, 138.1, 139.3 ppm. IR (KBr): ν = 3525, 3029,
˜
1490, 1386, 1257, 1025 cm–1. HRMS-ESI: m/z [M + Na]+ calcd.
for C18H22O2: 293.15120; found: 293.15114.
1
10.6 min. H NMR (200 MHz, CDCl3): δ = 3.61 (d, J = 1.0 Hz, 1
(1R,2R)-2-Isopropyloxy-1,2-diphenylethanol (18): Yield 185 mg,
72%, colorless liquid. [α]2D5 = +11.7 (c = 0.85, CH2Cl2); ee = 89%.
The enantiomeric assay: Chiralcel OD, isocratic (n-hexane/iPrOH,
97:3, flow 1 mL/min) λmax = 203 nm, (1S,2S): 6.5 min; (1R,2R):
H, OH), 3.87 (ddt, J = 12.5, 5.5, 1.5 Hz, 1 H, OCHAHB), 4.04 (ddt,
J = 12.5, 5.5, 1.5 Hz, 1 H, OCHAHB), 4.33 (d, J = 8.5 Hz, 1 H,
CHOCH2), 4.73 (dd, J = 8.5, 1.0 Hz, 1 H, CHOH), 5.19–5.34 (m,
2 H, CH=CH2), 5.86–5.98 (m, 1 H, CH=CH2), 7.01–7.28 (m, 10
H, ArH) ppm. 13C NMR (50 MHz, CDCl3): δ = 69.7, 78.6, 86.8,
105.4, 117.3, 127.3, 127.7, 127.8, 128.0, 128.1, 134.3, 137.6, 139.2
1
7.7 min. H NMR (200 MHz, CDCl3): δ = 1.12 (d, J = 6.0 Hz, 3
H, CH3), 1.20 (d, J = 6.0 Hz, 3 H, CH3), 1.57 (br. s, 1 H, OH),
3.57 (hept, J = 6.0 Hz, 1 H, CH(CH3)2), 4.30 (d, J = 8.5 Hz, 1 H,
CHOCH), 4.59 (d, J = 8.5 Hz, 1 H, CHOH), 6.98–7.25 (m, 10 H,
ArH) ppm. 13C NMR (50 MHz, CDCl3): δ = 21.2, 23.5, 69.7, 78.5,
84.8, 127.2, 127.5, 127.6, 127.7, 127.8, 138.6, 139.3 ppm. IR (film):
ppm. IR (film): ν = 3455, 3031, 2867, 1647, 1453, 1339, 1196,
˜
1074 cm–1. HRMS-ESI: m/z [M + Na]+ calcd. for C17H18O2:
277.11990; found: 277.11978.
ν = 3550, 2971, 2887, 1603, 1453, 1383, 1196, 1122 cm–1. HRMS-
(1R,2R)-2-(4-Methoxybenzyloxy)cyclohexanol (7):[23] Yield 213 mg,
90%, colorless liquid. [α]2D5 = –25.0 (c = 1.6, CH2Cl2); ee = 54%.
The enantiomeric assay: Chiral GC analysis 15 m (2,6-Me-3-pen-
tyl-γ-CD), 135° (50% in OV 1701). (1R,2R): 38.2 min, (1S,2S):
39.1 min. 1H NMR (300 MHz, CDCl3): δ = 1.20–1.26 (m, 4 H,
CH2), 1.69–1.77 (m, 2 H, CH2), 1.95–2.21 (m, 2 H, CH2), 2.68 (s,
1 H, OH), 3.10–3.22 (m, 1 H, CHOCH2), 3.40–3.52 (m, 1 H,
CHOH), 3.80 (s, 3 H, OCH3), 4.39 (d, J = 11.0 Hz, 1 H, OCHAHB),
4.63 (d, J = 11.0 Hz, 1 H, OCHAHB), 6.89 (d, J = 8.5 Hz, 2 H,
ArH), 7.27 (d, J = 8.5 Hz, 2 H, ArH) ppm. 13C NMR (75 MHz,
CDCl3): δ = 23.9, 24.2, 29.2, 32.0, 55.2, 70.4, 73.7, 83.1, 113.8,
˜
ESI: m/z [M + Na]+ calcd. for C17H20O2: 279.13555; found:
279.13552.
(1R,2R)-1,2-Diphenyl-2-(prop-2-ynyloxy)ethanol (19): Yield 184 mg,
73%, colorless liquid. [α]2D5 = –69.2 (c = 1.3, CH2Cl2); ee = 91%.
The enantiomeric assay: Chiralcel OD, isocratic (n-hexane/iPrOH,
90:10, flow 0.8 mL/min) λmax = 207 nm, (1S,2S): 11.4 min, (1R,2R):
1
13.4 min. H NMR (300 MHz, CDCl3): δ = 2.46 (t, J = 2.5 Hz, 1
H, alkyne-CH), 3.46 (d, J = 1.5 Hz, 1 H, OH), 3.93 (dd, J = 15.5,
2.5 Hz, 1 H, OCHAHB), 4.21 (dd, J = 15.5, 2.5 Hz, 1 H, OCHAHB),
4.50 (d, J = 8.5 Hz, 1 H, CHOCH2), 4.72 (dd, J = 8.5, 1.5 Hz, 1
H, CHOH), 7.00–7.25 (m, 10 H, ArH) ppm. 13C NMR (75 MHz,
CDCl3): δ = 56.2, 75.2, 78.5, 79.5, 86.4, 127.6, 128.0, 128.1, 128.2,
129.3, 130.7, 159.2 ppm. IR (film): ν = 3438, 2998, 2861, 1610,
˜
1511, 1299, 1079, 1033 cm–1. HRMS-ESI: m/z [M + Na]+ calcd.
for C14H20O3: 259.13047; found: 259.13064.
128.4, 128.6, 136.7, 139.1 ppm. IR (film): ν = 3453, 3031, 1603,
˜
1454, 1196, 1082 cm–1. HRMS-ESI: m/z [M + Na]+ calcd. for
(1R,2R)-2-(Allyloxy)cyclohexanol (8):[26] Yield 84 mg, 54%, color-
less liquid. [α]2D5 = –20.5 (c = 1.2, CH2Cl2); ee = 50%. The enantio-
meric assay: Chiral GC analysis 25 m (FS-Hydrodex β-3-P).
(1S,2S): 20.81 min, (1R,2R): 21.13 min. 1H NMR (300 MHz,
CDCl3): δ = 1.05–1.40 (m, 4 H, CH2), 1.60–1.80 (m, 2 H, CH2),
1.95–2.15 (m, 2 H, CH2), 2.75 (s, 1 H, OH), 3.04–3.14 (m, 1 H,
CHOCH2), 3.40–3.52 (m, 1 H, CHOH), 3.97 (ddt, J = 12.5, 5.5,
1.5 Hz, 1 H, OCHAHB), 4.17 (ddt, J = 12.5, 5.5, 1.5 Hz, 1 H, OCH-
AHB), 5.18 (dq, J = 10.5, 1.5 Hz, 1 H, CH=CHAHB), 5.29 (dd, J =
17.0, 1.5 Hz, 1 H, CH=CHAHB), 5.95 (ddt, J = 17.0, 10.5, 5.5 Hz, 1
H, CH = CH2) ppm. 13C NMR (75 MHz, CDCl3): δ = 23.9, 24.2,
C17H16O2: 275.10425; found: 275.10349.
(1R,2R)-2-Methoxy-2-(naphthalen-3-yl)-1-(naphthalen-6-yl)ethanol
(20): Yield 273 mg, 83%, white solid, m.p. 98–99 °C. [α]2D5 = +184.6
(c = 0.65, CH2Cl2); ee = 98%. The enantiomeric assay: Chiralcel
OD, isocratic (n-hexane/iPrOH, 95:5, flow 0.8 mL/min) λmax
=
210 nm, (1R,2R): 29.5 min, (1S,2S): 31.1 min. 1H NMR (200 MHz,
CDCl3): δ = 3.38 (s, 3 H, OCH3), 3.75 (d, J = 1.0 Hz, 1 H, OH),
4.42 (d, J = 8.5 Hz, 1 H, CHOCH3), 4.99 (dd, J = 8.5, 1.0 Hz, 1
H, CHOH), 7.09–7.20 (m, 2 H, ArH), 7.39–7.82 (m, 12 H, ArH)
ppm. 13C NMR (50 MHz, CDCl3): δ = 57.1, 78.6, 89.2, 125.3,
125.4, 125.8, 126.1, 126.4, 127.3, 127.5, 127.6, 127.7, 128.0, 133.0,
29.2, 32.0, 69.7, 73.7, 83.2, 116.9, 135.1 ppm. IR (film): ν = 3439,
˜
2933, 2861, 1647, 1451, 1302, 1233, 1882 cm–1. MS (ESI): m/z =
135.0, 136.8 ppm. IR (KBr): ν = 3444, 3019, 2890, 1600, 1506,
˜
179.1 [M + Na]+, 335.2 [2M + Na]+.
1361, 1268, 1162, 1062 cm–1. HRMS-ESI: m/z [M + Na]+ calcd.
(1R,2R)-2-Methoxy-1,2-diphenylethanol (16):[21] Yield 185 mg,
81%, white solid, m.p. 69–70 °C. [α]2D5 = +53.3 (c = 1.5, CHCl3); ee
= 92%. The enantiomeric assay: Chiralcel OD, isocratic (n-hexane/
iPrOH, 90:10, flow 0.8 mL/min) λmax = 203 nm, (1S,2S): 7.8 min;
for C23H20O2: 351.13555; found: 351.13527.
(1R,2R)-2-Methoxy-1,2-di-m-tolylethanol (21): Yield 197 mg, 77%,
colorless liquid. [α]2D5 = +70.0 (c = 1.0, CH2Cl2); ee = 96%. The
enantiomeric assay: Chiralcel OD, isocratic (n-hexane/iPrOH, 95:5,
flow 0.8 mL/min) λmax = 203 nm, (1S,2S): 9.8 min, (1R,2R):
10.9 min. 1H NMR (300 MHz, CDCl3): δ = 2.24 (s, 3 H, CH3),
2.26 (s, 3 H, CH3), 3.31 (s, 3 H, OCH3), 3.47 (s, 1 H, OH), 4.08 (d,
J = 8.5 Hz, 1 H, CHOCH3), 4.61 (d, J = 8.5 Hz, 1 H, CHOH),
6.77–7.20 (m, 8 H, ArH) ppm. 13C NMR (75 MHz, CDCl3): δ =
21.6, 57.2, 78.7, 89.3, 124.7, 125.2, 127.8, 128.1, 128.6, 128.9, 137.5,
1
(1R,2R): 8.7 min. H NMR (200 MHz, CDCl3): δ = 3.31 (s, 3 H,
OCH3), 3.51 (s, 1 H, OH), 4.12 (d, J = 8.5 Hz, 1 H, CHOCH3),
4.65 (d, J = 8.5 Hz, 1 H, CHOH), 6.97–7.23 (m, 10 H, ArH) ppm.
13C NMR (50 MHz, CDCl3): δ = 56.8, 78.6, 89.1, 127.2, 127.6,
127.7, 127.8, 128.0, 137.3, 139.1 ppm. IR (KBr): ν = 3405, 3061,
˜
1492, 1453, 1337, 1201, 1102, 1059 cm–1. HRMS-ESI: m/z [M +
Na]+ calcd. for C15H16O2: 251.10425; found: 251.10446.
137.7, 137.8, 139.5 ppm. IR (film): ν = 3463, 2979, 2823, 1606,
˜
1508, 1382, 1182, 973 cm–1. HRMS-ESI: m/z [M + Na]+ calcd. for
(1R,2R)-2-Butoxy-1,2-diphenylethanol (17): Yield 216 mg, 80%,
white solid, m.p. 55–56 °C. [α]2D5 = +31.2 (c = 1.6, CH2Cl2); ee =
94%. The enantiomeric assay: Chiralcel OD, isocratic (n-hexane/
C17H20O2: 279.13555; found: 279.13561.
(1R,2R)-1,2-Bis(4-chlorophenyl)-2-(4-methoxybenzyloxy)ethanol
iPrOH, 95:5, flow 1 mL/min) λmax = 203 nm, (1S,2S): 6.3 min, (22): Yield 303 mg, 75%, white solid, m.p. 72–74 °C. [α]2D5 = +28.8
(1R,2R): 7.1 min. 1H NMR (200 MHz, CDCl3): δ = 0.94 (t, J =
7.0 Hz, 3 H, CH3), 1.41–1.51 (m, 2 H, CH2), 1.58–1.71 (m, 2 H,
CH2), 3.35–3.47 (m, 2 H, OCH2), 3.67 (d, J = 1.0 Hz, 1 H, OH),
4.23 (d, J = 8.5 Hz, 1 H, CHOCH2), 4.68 (dd, J = 8.5, 1.0 Hz, 1
H, CHOH), 7.00–7.25 (m, 10 H, ArH) ppm. 13C NMR (50 MHz,
(c = 1.2, CHCl3); ee = 92%. The enantiomeric assay: Chiralcel OD,
isocratic (n-hexane/iPrOH, 95:5, flow 1.0 mL/min) λmax = 203 nm,
(1S,2S): 19.8 min, (1R,2R): 22.3 min. 1H NMR (300 MHz, CDCl3):
δ = 3.47 (s, 1 H, OH), 3.82 (s, 3 H, OCH3), 4.24 (d, J = 8.5 Hz, 1
H, CHOCH2), 4.24 (d, J = 11.0 Hz, 1 H, OCHAHB), 4.44 (d, J =
2324
www.eurjoc.org
© 2007 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2007, 2318–2327